Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Adapted Physical Activity in Patients With Advanced Pancreatic Cancer: The APACaP GERCOR Randomized Trial.
Neuzillet C, Bouché O, Tournigand C, Chibaudel B, Bauguion L, Bengrine-Lefevre L, Lopez-Trabada Ataz D, Mabro M, Metges JP, Péré-Vergé D, Conroy T, Lièvre A, Andre M, Desseigne F, Goldwasser F, Henriques J, Anota A, Hammel P. Neuzillet C, et al. J Natl Compr Canc Netw. 2023 Dec;21(12):1234-1242.e17. doi: 10.6004/jnccn.2023.7065. J Natl Compr Canc Netw. 2023. PMID: 38081120 Clinical Trial.
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients.
Serova M, Tijeras-Raballand A, Dos Santos C, Albuquerque M, Paradis V, Neuzillet C, Benhadji KA, Raymond E, Faivre S, de Gramont A. Serova M, et al. Among authors: neuzillet c. Oncotarget. 2015 Aug 28;6(25):21614-27. doi: 10.18632/oncotarget.4308. Oncotarget. 2015. PMID: 26057634 Free PMC article.
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial.
de Guillebon E, Jimenez M, Mazzarella L, Betsou F, Stadler P, Peták I, Jeannot E, Chanas L, Servant N, Marret G, Duso BA, Legrand F, Kornerup KN, Bernhart SH, Balogh G, Dóczi R, Filotás P, Curigliano G, Bièche I, Guérin J, Dirner A, Neuzillet C, Girard N, Borcoman E, Larbi Chérif L, Tresca P, Roufai DB, Dupain C, Scholl S, André F, Fernandez X, Filleron T, Kamal M, Le Tourneau C. de Guillebon E, et al. Among authors: neuzillet c. ESMO Open. 2021 Jun;6(3):100106. doi: 10.1016/j.esmoop.2021.100106. Epub 2021 Apr 14. ESMO Open. 2021. PMID: 33865192 Free PMC article. Review.
Intramural duodenal hematoma as a complication of paraduodenal pancreatitis.
Neuzillet C, Facchiano E, Palazzo L, Sabaté JM, Jouët P, Grossin M, Leroy C, Coffin B, Msika S, Kianmanesh R. Neuzillet C, et al. Clin Res Hepatol Gastroenterol. 2011 Feb;35(2):140-2. doi: 10.1016/j.clinre.2010.11.003. Clin Res Hepatol Gastroenterol. 2011. PMID: 21809489 No abstract available.
Targeting the TGFβ pathway for cancer therapy.
Neuzillet C, Tijeras-Raballand A, Cohen R, Cros J, Faivre S, Raymond E, de Gramont A. Neuzillet C, et al. Pharmacol Ther. 2015 Mar;147:22-31. doi: 10.1016/j.pharmthera.2014.11.001. Epub 2014 Nov 6. Pharmacol Ther. 2015. PMID: 25444759 Free article. Review.
Unraveling galectin-1 as a novel therapeutic target for cancer.
Astorgues-Xerri L, Riveiro ME, Tijeras-Raballand A, Serova M, Neuzillet C, Albert S, Raymond E, Faivre S. Astorgues-Xerri L, et al. Among authors: neuzillet c. Cancer Treat Rev. 2014 Mar;40(2):307-19. doi: 10.1016/j.ctrv.2013.07.007. Epub 2013 Aug 1. Cancer Treat Rev. 2014. PMID: 23953240 Review.
Prognostic factors for resectable pancreatic adenocarcinoma.
Neuzillet C, Sauvanet A, Hammel P. Neuzillet C, et al. J Visc Surg. 2011 Sep;148(4):e232-43. doi: 10.1016/j.jviscsurg.2011.07.007. Epub 2011 Sep 15. J Visc Surg. 2011. PMID: 21924695 Free article. Review.
130 results